Sign in to view content

A Phase I Study to Evaluate the Tie2 Agonist RO7446603, Alone or in Combination With Aflibercept orFaricimab, in Diabetic Macular Edema

Jeremiah Brown, MD, MS, FASRS

Video
Published 2025

Related

Obstructive Sleep Apnea as a Risk Factor for Diabetic Retinopathy Progression and Systemic Complications
Ehsan Rahimy, MD
Annual Meeting Talks
2024
Clinical Utility of the Fellow Eye in Patients With Bilateral GA Due to AMD: Long-Term Data from the Pegcetacoplan Clinical Program
Diana V Do, MD, FASRS
Updates from the Field
2025
Intravitreal Gene Therapy for Diabetic Macular Edema With ADVM-022: First-Time Data Presentation of Prospective, Randomized Phase 2 INFINITY Trial
Charles C Wykoff, MD, PhD, FASRS
Annual Meeting Talks
2021

Category: Diabetic Retinopathy

See more